Report Categories
View AllRecent Articles
View All
NovoCure Limited NVCR Stock Analysis Falls 260 Watching 1670 20260515
AsiaPacific Markets Eye Higher Open as TrumpXi Summit Kicks Off in Beijing
Valley VLYPO Q1 2026 Results Top Views on Strong Revenue
New York Fed Study Reveals Disproportionate Impact of Rising Gas Prices on LowerIncome Households
US Arms Sales to Taiwan Paused Amid Iran Conflict Acting Navy Chief Confirms
Meta Cloud Computing Business Definitely on the Table Zuckerberg Says
Merck Foundation and Ghana First Lady Reinforce LongTerm Healthcare and Education Partnership
Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal
Meta Floats Potential Cloud Computing Business as Data Center Expansion Continues
Goldman Sachs Warns Agentic AI Expansion Hinges on Physical Infrastructure Not Just Semiconductors
TDS Q1 2026 Earnings Massive EPS Surprise of 3475 as Profitability Defies Expectations
Nexstar Media Group NXST Q1 2026 Earnings EPS Beats Estimates by Over 13 Despite Flat Revenue Outlook
PSX Q1 2026 Earnings Massive EPS Surprise Drives Shares Higher
OBK Q1 2026 Earnings Earnings Miss but Stock Rises Amid Resilient Core Operations
Red Violet Inc RDVT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction
CPRI Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher
CO2 Energy Transition Corp NOEM Holds Steady Near Trust Value as Support and Resistance Levels Defined
Pangaea Logistics Solutions PANL Slips 275 as Support Level Comes into Focus
Flutter Entertainment FLUT Gains 2 as Shares Approach Key Resistance Level
Praetorian Acquisition Corp Units PTORU Holding Steady at 100 Analysis of Key Levels and Potential Catalysts
BXP Inc Holds Steady Near 60 Support and Resistance Levels in Focus
Iron Horse Acquisitions Rights IRHOR Slips Nearly 6 as Rights Trade Near Support Levels
New Providence Acquisition Corp III NPAC Holds Steady at 1034 Amid SPAC Market Calm
Futu Holdings Plunges Over 27 Key Support Levels in Focus
Arqit Quantum ARQQ Slides Nearly 3 as Support Levels Come into Focus
BioXcel Therapeutics BTAI Slips 088 as Stock Tests Support Near 107